Regulatory affairs are fundamental milestones in the development of new drugs and the execution of clinical research projects. An effective administrative application can accelerate time to market, offer better therapies to patients earlier, and maximize research investments. Our regulatory affairs department handles the preparation, review, submission and follow-up of applications to regulatory agencies at both national and international levels. We help to find the most suitable pathways to administrative approval for new pharmaceutical products through close relationships with local competent authorities, reducing time to commercialization. Our catalog of services related to regulatory affairs includes study approval applications, marketing authorization applications of new drugs, communication with competent authorities and insurance policy management.